Prostate Cancer Clinical Trials
CRB-701
A Phase 1/2 Study to Investigate the Safety, Pharmacokinetics, and Efficacy of CRB-701, an Antibody-drug Conjugate Targeting Nectin-4, in Patients with Advanced Solid Tumors
PROMISE REGISTRY
A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness